Similar articles

• Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis.

  Vercellini P, De Giorgi O, Oldani S, Cortesi I, Panazza S, Crosignani PG. Vercellini P, et al. Am J Obstet Gynecol. 1996 Aug;175(2):396-401. doi: 10.1016/s0002-9378(96)70152-7. Am J Obstet Gynecol. 1996. PMID: 8765259 Clinical Trial.
• Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain.

  Crosignani PG, Luciano A, Ray A, Bergqvist A. Crosignani PG, et al. Hum Reprod. 2006 Jan;21(1):248-56. doi: 10.1093/humrep/dei290. Epub 2005 Sep 21. Hum Reprod. 2006. PMID: 16176939 Clinical Trial.
• Premenopausal bone loss and depot medroxyprogesterone acetate administration.

  Mark S. Mark S. Int J Gynaecol Obstet. 1994 Dec;47(3):269-72. doi: 10.1016/0020-7292(94)90572-x. Int J Gynaecol Obstet. 1994. PMID: 7705533
• Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis.

  Barra F, Scala C, Ferrero S. Barra F, et al. Expert Opin Drug Metab Toxicol. 2018 Apr;14(4):399-415. doi: 10.1080/17425255.2018.1461840. Epub 2018 Apr 10. Expert Opin Drug Metab Toxicol. 2018. PMID: 29617576 Review.
• The role of progestins in treating the pain of endometriosis.

  Surrey ES. Surrey ES. J Minim Invasive Gynecol. 2006 Nov-Dec;13(6):528-34. doi: 10.1016/j.jmig.2006.06.008. J Minim Invasive Gynecol. 2006. PMID: 17097575 Review.